Search Results (590)

In Liquid Composite Molding (LCM), the high variability present in reinforcement properties such as permeability creates additional challenges during the injection process, such as void formation. Although improved injection strategy designs can mitigate the formation of defects, these processes can benefit from real-time process monitoring and control to adapt the injection conditions when needed. In this study, a machine vision algorithm is proposed, with the objective of detecting and tracking both fluid flow and bubbles in an LCM setup. In this preliminary design, 3D-printed porous geometries are used to mimic the architecture of textile reinforcements. The results confirm the applicability of the proposed approach, as the detection and tracking of the objects of interest is possible, without the need to incur in elaborate experimental preparations, such as coloring the fluid to increase contrast, or complex lighting conditions. Additionally, the proposed approach allowed for the formulation of a new dimensionless number to characterize bubble transport efficiency, offering a quantitative metric for evaluating void transport dynamics. This research underscores the potential of data-driven approaches in addressing manufacturing challenges in LCM by reducing the overall process monitoring complexity, as well as using the acquired reliable data to develop robust, data-driven models that offer new understanding of process dynamics and contribute to improving manufacturing efficiency. Full article

Reducing the carbon footprint of the construction sector is a growing priority. This study explores the potential of using submerged arc welding (SAW) slag as a precursor in the development of low-carbon geopolymeric materials for 3D printing. The influence of potassium hydroxide (KOH) molarity, partial replacement of ground granulated blast furnace slag (GGBFS) with SAW slag, and water-to-binder (w/b) ratio was evaluated in terms of fresh and hardened properties. Increasing KOH molarity delayed setting times, with the longest delays at 10 M and 12 M. The highest compressive strength (48.5 MPa at 28 days) was achieved at 8 M; higher molarities led to strength losses due to excessive precursor dissolution and increased porosity. GGBFS replacement increased setting times due to its higher Al₂O₃ and MgO content, which slowed geopolymerization. The optimized formulation, containing 20% SAW slag and activated with 8 M KOH at a w/b ratio of 0.29, exhibited good workability, extrudability, and shape retention. This mixture also performed best in 3D printing trials, strong layer adhesion and no segregation, although minor edge irregularities were observed. These results suggest that SAW slag is a promising sustainable material showing for 3D-printed geopolymers, with further optimization of printing parameters needed to enhance surface quality. Full article

Edible hydrogels are the central material class in 3D food printing because they reconcile two competing needs: (i) low resistance to flow under nozzle shear and (ii) fast recovery of elastic structure after deposition to preserve geometry. This review consolidates the recent years of progress on hydrogel formulations—gelatin, alginate, pectin, carrageenan, agar, starch-based gels, gellan, and cellulose derivatives, xanthan/konjac blends, protein–polysaccharide composites, and emulsion gels alongside a critical analysis of printing technologies relevant to food: extrusion, inkjet, binder jetting, and laser-based approaches. For each material, this review connects gelation triggers and compositional variables to rheology signatures that govern printability and then maps these to process windows and post-processing routes. This review consolidates a decision-oriented workflow for edible-hydrogel printability that links formulation variables, process parameters, and geometric fidelity through standardized test constructs (single line, bridge, thin wall) and rheology-anchored gates (e.g., yield stress and recovery). Building on these elements, a “printability map/window” is formalized to position inks within actionable operating regions, enabling recipe screening and process transfer. Compared with prior reviews, the emphasis is on decisions: what to measure, how to interpret it, and how to adjust inks and post-set enablers to meet target fidelity and texture. Reporting minima and a stability checklist are identified to close the loop from design to shelf. Full article

Rapid population growth and accelerating urbanization are intensifying the demand for construction materials, particularly concrete, which is predominantly produced with Portland cement and natural aggregates. This reliance imposes substantial environmental burdens through resource depletion and greenhouse gas emissions. Within the framework of sustainable construction, recycled aggregates and industrial by-products such as fly ash, slags, crushed glass, and other secondary raw materials have emerged as viable substitutes in concrete production. At the same time, three-dimensional concrete printing (3DCP) offers opportunities to optimize material use and minimize waste, yet it requires tailored mix designs with controlled rheological and mechanical performance. This review synthesizes current knowledge on the use of recycled construction and demolition waste, industrial by-products, and geopolymers in concrete mixtures for 3D printing applications. Particular attention is given to pozzolanic activity, particle size effects, mechanical strength, rheology, thermal conductivity, and fire resistance of recycled-based composites. The environmental assessment is considered through life-cycle analysis (LCA), emphasizing carbon footprint reduction strategies enabled by recycled constituents and low-clinker formulations. The analysis demonstrates that recycled-based 3D printable concretes can maintain or enhance structural performance while mix-level (cradle-to-gate, A1–A3) LCAs of printable mixes report CO₂ reductions typically in the range of ~20–50% depending on clinker substitution and recycled constituents—with up to ~48% for fine recycled aggregates when accompanied by cement reduction and up to ~62% for mixes with recycled concrete powder, subject to preserved printability. This work highlights both opportunities and challenges, outlining pathways for advancing durable, energy-efficient, and environmentally responsible 3D-printed construction materials. Full article

Background: Sustained-release (SR) formulations of non-steroidal anti-inflammatory drugs (NSAIDs) aim to prolong therapeutic activity, reduce dosing frequency, and improve patient adherence. However, currently marketed SR NSAIDs exhibit persistent limitations, including incomplete control over release kinetics, high interpatient variability in bioavailability, limited reduction in gastrointestinal adverse effects, and insufficient dose flexibility for individualized therapy. In many cases, conventional excipients and release mechanisms remain predominant, leaving drug-specific physicochemical and pharmacokinetic constraints only partially addressed. These gaps highlight the need for a comprehensive synthesis of recent technological advances to guide the development of more effective, patient-centered delivery systems. Methods: A narrative literature review was conducted using Web of Science and PubMed databases to identify original research articles and comprehensive technological studies on oral SR formulations of NSAIDs and paracetamol published between January 2020 and March 2025. Inclusion criteria focused on preclinical and technological research addressing formulation design, excipient innovations, and manufacturing approaches. Results: Sixty-four studies met the inclusion criteria, encompassing polymeric matrices (31%), lipid-based carriers (18%), microspheres/hydrogel beads/interpenetrating polymer networks (30%), nanostructured systems (11%), and hybrid platforms (10%). The most common strategies involved pH-dependent release, mucoadhesive systems, and floating drug delivery, aiming to optimize release kinetics, minimize mucosal irritation, and sustain therapeutic plasma levels. Advances in manufacturing—such as hot-melt extrusion, 3D printing, electrospinning, and spray drying—enabled enhanced control of drug release profiles, improved stability, and in some cases up to 30–50% prolongation of release time or reduction in Cmax fluctuations compared with conventional formulations. Conclusions: Recent formulation strategies show substantial potential to overcome long-standing limitations of SR NSAID delivery, with expected benefits for patient compliance and quality of life through reduced dosing frequency, better tolerability, and more predictable therapeutic effects. Nevertheless, integration of in vitro performance with pharmacokinetic and clinical safety outcomes remains limited, and the translation to clinical practice is still in its early stages. This review provides a comprehensive overview of current technological trends, identifies persisting gaps, and proposes future research directions to advance SR NSAID systems toward safer, more effective, and patient-focused therapy. Full article

Three-dimensional (3D) bioprinting has become one of the most advanced and useful innovations that allows the creation of personalized macroscopic and microscopic constructs at different scales that match a patient’s anatomy. Intensive research efforts are currently underway to develop highly printable and biocompatible materials. Among the variety of bioprinting materials (i.e., biomaterial inks), naturally derived hydrogels have attracted great interest due to their beneficial properties in terms of biocompatibility, cost-effectiveness, and biodegradability. In this proceeding paper, we provide an overview of the formulation and use of three functional polysaccharides as ink-based hydrogels. First, 3D bioprinting is summarized as revolutionary technology that is able to create cell-laden structures layer by layer in a specific pattern that mimics native tissue and organs. Cellulose, chitosan, and lignin are presented below, followed by an overview of their applicability in 3D bioprinting, focusing on printability and the resulting printed 3D structures as illustrated in various published figures. In the same way, a comparative overview of 3D bioprinting applications is summarized. Finally, a section dedicated to comparisons, limitations, and crosslinking strategies is provided. It is worth noting that this proceedings paper provides a brief overview rather than a comprehensive review, as it is limited by page constraints and is based on the content of our poster presented at the 1st International Online Conference on Bioengineering. Full article

This study presents a novel strategy for designing photocurable resins tailored for the additive manufacturing of smart thermoset materials. A quaternary formulation was developed by integrating bis(2-methacryloyl)oxyethyl disulfide (DADS) with an epoxy/thiol-ene system (ETES) composed of diglycidyl ether of bisphenol A (EP), pentaerythritol tetrakis(3-mercaptopropionate) (PTMP), and 4,4′-methylenebis(N,N-diallylaniline) (ACA4). This unique combination enables the simultaneous activation of four polymerization mechanisms: radical photopolymerization, thiol-ene coupling, thiol-Michael addition, and anionic ring-opening, within a single resin matrix. A key innovation lies in the exothermic nature of DADS photopolymerization, which initiates and sustains ETES curing at room temperature, enabling 3D printing without thermal assistance. This represents a significant advancement over conventional systems that require elevated temperatures or post-curing steps. The resulting hybrid poly(acrylate–co-ether–co-thioether) network exhibits enhanced mechanical integrity, shape memory behavior, and intrinsic self-healing capabilities. Dynamic Mechanical Analysis revealed a shape fixity and recovery of 93%, while self-healing tests demonstrated a 94% recovery of viscoelastic properties, as evidenced by near-overlapping storage modulus curves compared to a reference sample. This integrated approach broadens the design space for multifunctional photopolymers and establishes a versatile platform for advanced applications in soft robotics, biomedical devices, and sustainable manufacturing. Full article

The increasing demand for novel tissue engineering (TE) applications in bone tissue regeneration underscores the importance of exploring advanced manufacturing techniques and biomaterials for personalised treatment approaches. Three-dimensional printing (3DP) technology facilitates the development of implantable devices with intricate geometries, enabling patient-specific therapeutic solutions. Although Fused Filament Fabrication (FFF) and Direct Ink Writing (DIW) are widely utilised for fabricating bone-like implants, the need for multiple processing steps often prolongs the overall production time. In this study, a single-step melt-extrusion 3DP technique was performed to develop multi-material scaffolds including bioceramics, hydroxyapatite (HA), and β-tricalcium phosphate (TCP) in both their bioactive and calcined forms at 10% and 20% w/w, within polycaprolactone (PCL) matrices. Printing parameters were optimised, and physicochemical properties of all biomaterials and final forms were evaluated. Thermal degradation and surface morphology analyses assessed the consistency and distribution of the ceramics across the different formulations. The tensile testing of the scaffolds defined the impact of each ceramic type and wt% on scaffold flexibility performance, while in vitro cell studies determined the cytocompatibility efficiency. Hence, all 3D-printed PCL–ceramic composite scaffolds achieved structural integrity and physicochemical and thermal stability. The mechanical profile of extruded samples was relevant to the ceramic consistency, providing valuable insights for further mechanotransduction investigations. Notably, all materials showed high cell viability and proliferation, indicating strong biocompatibility. Therefore, this additive manufacturing (AM) process is a precise and fast approach for developing biomaterial-based scaffolds, with potential applications in surgical restoration and support of segmental bone defects. Full article

Amorphous solid dispersions (ASDs) provide an effective approach to overcome the poor solubility of many active pharmaceutical ingredients and can facilitate their uniform distribution within hydrogel matrices. Although ASDs are well recognized in oral formulations, their use with hydrogels for wound care remains underexplored. Hydrogels not only offer a biocompatible environment for healing wounds but also are highly versatile for 3D printing, enabling the design of patient-specific dressings customized in composition and structure. This review emphasizes the therapeutic potential of combining ASDs with hydrogel platforms, focusing on how these systems can speed up wound healing, minimize complications, and support personalized therapies. The physicochemical basis for amorphization with limitations and the synergistic effects of bioactive hydrogels are discussed to provide a conceptual basis for advancing this innovative strategy in chronic wound treatment. Full article

Additive manufacturing using fused deposition modelling (FDM) is increasingly explored for personalised drug delivery, but the lack of suitable biodegradable and printable filaments limits its pharmaceutical application. In this study, we investigated the influence of formulation and structural design on the performance of polyvinyl alcohol (PVA)-based filaments doped with theophylline anhydrous for 3D printing. To address the intrinsic brittleness and poor printability of PVA, cassava pulp-derived fibres—a sustainable and underutilised agricultural by-product—were incorporated together with polyethylene glycol (PEG 400), Eudragit^® NE 30 D, and calcium stearate. The addition of fibres modified the mechanical properties of PVA filaments through hydrogen bonding, improving flexibility but increasing surface roughness. This drawback was mitigated by Eudragit^® NE 30 D, which enhanced surface smoothness and drug distribution uniformity. The optimised composite formulation (P₁₀F₅E₅T₅) was successfully extruded and used to fabricate 3D-printed constructs. Release studies demonstrated that drug release could be modulated by pore geometry and construct thickness: wider pores enabled rapid Fickian diffusion, while narrower pores and thicker constructs shifted release kinetics toward anomalous transport governed by polymer swelling. These findings demonstrate, for the first time, the potential of cassava fibre as a functional additive in pharmaceutical FDM and provide a rational formulation–structure–performance framework for developing sustainable, geometry-tuneable drug delivery systems. Full article

Objectives: To compare fracture toughness (FT), work of fracture (WOF) and Vickers hardness (HV) of four 3D-printed denture base resins—including two novel formulations—and one conventional cold-cured polymethylmethacrylate (PMMA) resin. Methods: 3D-printed specimens (Freeprint denture (FD)/denture impact (FDI), DETAX GmbH and V-Print dentbase/dentbase 2.0, VOCO GmbH) were fabricated at 90° layer orientation (n = 40/group) and notched according to ISO 20795-1. FT and WOF were measured via single-edge notched bend testing after seven-day water storage at 37 °C. HV was determined on fractured shards using 3 N load. Data were analyzed with Welch-ANOVA/Dunnett-T3 or ANOVA/Tukey (α = 0.05). Results: The conventional PMMA showed the highest FT and WOF, followed by the novel formulations of the 3D-printed groups VD2 and FDI. Lowest FT and WOF values were measured for VD and FD. HV was highest for the conventional PMMA, followed by the primary formulations FD and VD. Lowest hardness was measured for the novel formulations FDI and VD2. Conclusions: The formulations of the novel 3D-printed materials (FDI and VD2) exhibited markedly greater FT and WOF than their respective predecessors, although this improvement was accompanied by a decrease in hardness. Nevertheless, none of the 3D-printed materials fulfilled the ISO standard criteria for enhanced FT. Full article

Background/Objectives: Hospital compounding is essential for the delivery of patient-tailored therapies—particularly for pediatric and oncology patients and other groups requiring precise dosing. Its role is expected to grow as, for instance, the UK MHRA’s new Guidance on Decentralised Manufacturing promotes alternative manufacturing pathways that integrate hospital preparation units. However, drug substances that remain stable in commercial oral formulations may undergo rapid degradation under alternative conditions (e.g., aqueous suspension, light exposure, or in the presence of specific excipients). Despite these risks, formulation strategies in hospital compounding often rely on empirical practices and lack structured guidance regarding stability, impurity control, and reproducibility. Methods: This study proposes a risk-based scientific framework for formulation design, integrating degradation profiling with predictive toxicology. Potential degradation pathways (hydrolytic, oxidative, and photolytic) are systematically identified through forced-degradation studies combined with ab initio modeling. These risks are translated into formulation strategies using a structured decision tree encompassing solvent selection, pH adjustment, excipient compatibility, and packaging considerations, even in the absence of a pharmacopeial monograph. The toxicological relevance of degradation products is evaluated using in silico approaches aligned with ICH M7 guidelines, thereby defining critical quality attributes (cQAs) and critical process parameters (CPPs). Results: The applicability of the framework is demonstrated through hospital compounding case studies, with further extension toward advanced applications such as semi-solid extrusion (SSE) 3D printing. Conclusions: By integrating mechanistic understanding of drug degradation into formulation planning, the proposed framework enhances the safety, reproducibility, and quality of compounded preparations. This approach reinforces Good Preparation Practices (GPPs) and is consistent with international quality-by-design (QbD) principles in the context of personalized medicine. Full article

High-performance concrete for 3D printing has recently attracted significant attention due to its potential to create structural elements without the need for traditional reinforcement. While various formulations have been proposed by researchers, evaluations are often limited to mechanical performance and printability, while cost and environmental impact are generally overlooked. This study expands the analysis by also considering cost and environmental impact, aiming to identify the optimal mix using a multi-criteria decision-making analysis (MCDMA). In the first phase, several high-strength mortar formulations were developed and assessed based on mechanical strength, printability, environmental impact, and cost. In the second phase, the most promising mix from the initial evaluation was further modified by incorporating different types of fibers, including aramid, carbon, glass, cellulose, and polypropylene. Comprehensive testing—covering mechanical properties and printability—together with cost and a life cycle assessment were conducted to determine the most effective mortar formulations. One of the main findings is that adding 0.05% of 20 mm length cellulose fibers in weight to a mortar containing Cem I 42.5R can increase the compressive strength by more than 9% without affecting the cost or environmental impact, also allowing the obtainment of a mortar apt for 3D printing. This increase in the compression strength is presumably related to a lateral restriction in movements of the mortar, which makes it increase the maximal principal stresses, and thus, its strength. Full article

Functional ingredients such as dietary fibers, probiotics and prebiotics, polyphenols, omega-3 fatty acids, and bioactive peptides are increasingly central to food systems that aim to deliver health benefits beyond basic nutrition. This review explores how molecular structure, physicochemical properties, metabolism, and microbiome interactions affect bioactivity and bioavailability. We highlight advances in green extraction, encapsulation technologies, and 3D/4D printing that enhance the stability and targeted delivery of bioactives. AI-enabled tools for ingredient discovery, structure–activity modeling, and personalized formulation are also discussed. Sensory research and market insights inform strategies to improve consumer acceptance, while clinical studies provide evidence for cardiometabolic, immune, and cognitive benefits. Safety and regulatory aspects are addressed, particularly for emerging proteins and delivery systems. By integrating scientific and technological developments across disciplines, this review provides a comprehensive foundation for future research and commercialization of safe, effective, and personalized functional food products. Full article

Background/Objectives: Neuropathic pain, resulting from damage or pathology affecting the somatosensory nervous system, is a prevalent form of chronic pain that significantly impacts quality of life. Combined therapies are often utilised to manage this condition. Three-dimensional printing (3DP) offers a promising approach for personalising medication doses and dosage forms to meet individual patient needs. Methods: In this study, a formulation suitable for 3D printing was developed using magnesium citrate, uridine monophosphate, vitamins B₃ (niacin), B₆ (pyridoxine), B₁₂ (cobalamin), B₉ (folic acid), and spermidine to create a novel gel-based oral tablet for the targeted treatment of neurological pain. The antioxidant potential of the active pharmaceutical ingredients (APIs) was assessed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) methods. The physical properties of the tablets were evaluated using a texture analyser, while the in vitro release profiles were determined by high-performance liquid chromatography (HPLC). Results: Results demonstrated that pectin–gelatin tablets hardened over time, with higher citric acid concentrations further enhancing this effect. Formulation AVII exhibited good hardness and low stickiness. Formulation AV, however, showed poor performance across all physical parameters and lacked sufficient structural integrity for practical application. While uridine monophosphate, B₁₂, and B₉ showed no significant differences in the release profiles of the tablets, spermidine, B₆, and B₃ displayed statistically significant variations. Specifically, AVII outperformed AV in terms of spermidine and B₆ release, and AV showed a higher release of B₃ compared to AV. Conclusions: The AVII tablet demonstrates potential for use in combined therapy targeting neurological pain disorders. Full article